National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 10 of 1997)

Administered by Department of Health, Disability and Ageing

Legislation au F2007B01085 Not in force Legislative Instrument

Legislation content

 

 

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUBSECTION 85 (2AA)

No. PB 10 of 1997

 

 

I, ALAN WILLIAM STEVENS, Acting Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Family Services and Delegate of the Minister for Health and Family Services, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:

 

  1. This Declaration shall come into operation on 1 August 1997.

 

2.                   The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

 

THE SCHEDULE

 

Cloxacillin Sodium

Fluoxymesterone

Ticarcillin Sodium

 

_____________________________________________________________________

 

Dated this 11th day of July 1997.

 

 

 

 

 

A. STEVENS

Acting Assistant Secretary

Pharmaceutical Benefits Branch

Department of Health and Family Services

Delegate of the Minister for Health and Family Services

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.